IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,459,000 | +16.8% | 75,000 | 0.0% | 0.14% | +11.5% |
Q4 2017 | $1,249,000 | -29.3% | 75,000 | -13.8% | 0.13% | -29.7% |
Q3 2017 | $1,766,000 | -37.3% | 87,000 | -50.3% | 0.18% | -44.4% |
Q2 2017 | $2,818,000 | +25.1% | 175,000 | +84.2% | 0.33% | -18.2% |
Q3 2016 | $2,252,000 | -17.8% | 95,000 | 0.0% | 0.41% | -21.0% |
Q2 2016 | $2,738,000 | -20.8% | 95,000 | -12.0% | 0.52% | -18.0% |
Q1 2016 | $3,458,000 | – | 108,000 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |